Painchek (ASX:PCK) Moat Score: 0/10 (As of Jul. 01, 2026)


ASX:PCK Painchek Ltd ASX:PCK
52 GF Score
Price A$0.11
GF Value A$0.40
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Painchek Moat Score?

Painchek has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Painchek has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Painchek might have No Moat - No discernible moat.

Painchek  (ASX:PCK) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Painchek Moat Score Related Terms

ASX:PCK
52GF Score
Painchek Ltd ASX:PCK
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Painchek (ASX:PCK) Overvalued in 2026?

Based on GuruFocus' analysis, Painchek stock appears to be undervalued. The current stock price of A$0.11 is trading 73.8% below its estimated GF Value™ of A$0.40. GuruFocus considers Painchek to be Possible Value Trap.

Key valuation signals for ASX:PCK:

  • Moat Score: 0
  • GF Value™: A$0.40 vs. price of A$0.11 (73.8% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ASX:PCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Painchek Business Description

Address 35 Lime Street, Suite 401, Sydney, NSW, AUS, 2000
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.
52GF Score

Get the complete analysis for ASX:PCK

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price
A$0.40
GF Value